On Invalid Date, Novartis Ag (NYSE: NVS) reported Q4 2022 earnings per share (EPS) of $0.69, up 90.53% year over year. Total Novartis Ag earnings for the quarter were $1.47 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $7.29.
As of Q1 2023, Novartis Ag's earnings has grown -70.21% year over year. This is 96.53 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 26.31%. Novartis Ag's earnings in the past year totalled $6.96 billion.
What was NVS's revenue last quarter?
On Invalid Date, Novartis Ag (NYSE: NVS) reported Q4 2022 revenue of $13.09 billion up 3.22% year over year. In the same quarter last year, Novartis Ag's revenue was $13.52 billion.
What was NVS's revenue growth in the past year?
As of Q1 2023, Novartis Ag's revenue has grown -1.98% year over year. This is 14.38 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.4%. Novartis Ag's revenue in the past year totalled $51.83 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.